These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3366400)

  • 1. [Digoxin-like material in liver disease].
    Shilo L; Shapiro MS; Shenkman L
    Harefuah; 1988 Mar; 114(5):224-5. PubMed ID: 3366400
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L; Zofra S; Imperato G; Adorno V; Maglione A
    Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin automated immunoassay.
    Lacarelle B; Durand A; Labadie N; Cano JP
    Ther Drug Monit; 1989 Nov; 11(6):725-7. PubMed ID: 2595757
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence of marked digoxin-like immunoreactivity in the human adrenal cortex: results of an immunohistochemical study.
    Ghione S; Balzan S; Braus S; Montali U; Bruno J
    Eur J Histochem; 1993; 37(3):273-6. PubMed ID: 7693066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assay.
    Kulaots IA; Pudek MR; Seccombe DW
    Clin Chem; 1987 Aug; 33(8):1490-1. PubMed ID: 3301074
    [No Abstract]   [Full Text] [Related]  

  • 6. Endogenous digoxin-like substance(s) and combined hepatic and renal failure.
    Gault MH; Vasdev SC; Longerich LL
    Ann Intern Med; 1984 Oct; 101(4):567-8. PubMed ID: 6548099
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 8. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
    Gervais A; Nanji AA; Greenway DC; McLean W
    Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-like immunoreactive substances and bile acids in the serum of patients with liver disease.
    Pudek MR; Seccombe DW; Humphries K
    Clin Chem; 1986 Oct; 32(10):2005-6. PubMed ID: 3757258
    [No Abstract]   [Full Text] [Related]  

  • 10. Digitoxin antibody cross-reactivity and evaluation of potential candidates for circulating digitalis-like immunoreactive factor.
    Graves SW; Naomi S; Williams GH; Hollenberg NK
    Clin Chem; 1994 Oct; 40(10):1977-8. PubMed ID: 7923784
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of endogenous digoxin-like substance in the pathogenesis of arterial hypertension in pregnancy].
    Soszyński P; Słowińska-Srzednicka J; Latoszewska-Smółko W
    Pol Tyg Lek; 1987 Sep; 42(37):1145-8. PubMed ID: 3432148
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endogenous digitalis-like substance. II. Relation to pathologic states and diseases].
    Martinka E
    Vnitr Lek; 1995 Oct; 41(10):719-23. PubMed ID: 8578707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLIS affects digoxin interpretation.
    Lee KR; Phelps SJ
    Am Pharm; 1993 Mar; NS33(3):6. PubMed ID: 8329041
    [No Abstract]   [Full Text] [Related]  

  • 14. Higher values for digitalis-like factors with TDx Digoxin II.
    Gault MH; Vasdev S; Longerich L
    Clin Chem; 1986 Oct; 32(10):2000-1. PubMed ID: 3757253
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous digoxin-like material in patients with liver disease.
    Shilo L; Shapiro MS; Dolev S; Shenkman L
    Ann Intern Med; 1985 Oct; 103(4):643. PubMed ID: 3839990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR; Vorwerk P; Fritsche K; Richter R
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of blood digoxin].
    Janssen K
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1254. PubMed ID: 2201511
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous digoxin-like immunoreactivity during pregnancy and at birth.
    Lupoglazoff JM; Jacqz-Aigrain E; Guyot B; Chappey O; Blot P
    Br J Clin Pharmacol; 1993 Mar; 35(3):251-4. PubMed ID: 8471401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antidopaminergic drugs on endogenous digoxin-like factor in psychiatric patients.
    Adawi A; Shilo L; Levy A; Neumann M; Shenkman L
    Isr J Med Sci; 1993 Aug; 29(8):466-8. PubMed ID: 8104913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.